NFAT activation by FKBP52 promotes cancer cell proliferation by suppressing p53

被引:0
|
作者
Hanaki, Shunsuke [1 ]
Habara, Makoto [1 ]
Tomiyasu, Haruki [1 ]
Sato, Yuki [1 ]
Miki, Yosei [1 ]
Masaki, Takahiro [1 ]
Shibutani, Shusaku [1 ,2 ]
Shimada, Midori [1 ,3 ]
机构
[1] Yamaguchi Univ, Dept Vet Biochem, Yamaguchi, Japan
[2] Yamaguchi Univ, Dept Vet Hyg, Yamaguchi, Japan
[3] Nagoya Univ, Grad Sch Med, Dept Mol Biol, Nagoya, Japan
基金
日本学术振兴会;
关键词
HSP90-BINDING IMMUNOPHILIN FKBP52; GLUCOCORTICOID-RECEPTOR; ONCOPROTEIN MDM2; EXPRESSION; PROTEIN; MICROTUBULES; PROGRESSION; MODULATION; APOPTOSIS; TARGET;
D O I
10.26508/lsa.202302426
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
FK506-binding protein 52 (FKBP52) is a member of the FKBP family of proline isomerases. FKBP52 is up -regulated in various cancers and functions as a positive regulator of steroid hormone receptors. Depletion of FKBP52 is known to inhibit cell proliferation; however, the detailed mechanism remains poorly understood. In this study, we found that FKBP52 depletion decreased MDM2 transcription, leading to stabilization of p53, and suppressed cell proliferation. We identi fied NFATc1 and NFATc3 as transcription factors that regulate MDM2 . We also found that FKBP52 associated with NFATc3 and facilitated its nuclear translocation. In addition, calcineurin, a well-known Ca 2+ phosphatase essential for activation of NFAT, plays a role in MDM2 transcription. Supporting this notion, MDM2 expression was found to be regulated by intracellular Ca 2+ . Taken together, these findings reveal a new role of FKBP52 in promoting cell proliferation via the NFAT-MDM2-p53 axis, and indicate that inhibition of FKBP52 could be a new therapeutic tool to activate p53 and inhibit cell proliferation.
引用
收藏
页数:13
相关论文
共 50 条
  • [21] FKBP25, a novel regulator of the p53 pathway, induces the degradation of MDM2 and activation of p53
    Ochocka, Anna Maria
    Kampanis, Petros
    Nicol, Samantha
    Allende-Vega, Nerea
    Cox, Miranda
    Marcar, Lynnette
    Milne, Diane
    Fuller-Pace, Frances
    Meek, David
    FEBS LETTERS, 2009, 583 (04): : 621 - 626
  • [22] Pseudogene PDIA3P1 promotes cell proliferation, migration and invasion, and suppresses apoptosis in hepatocellular carcinoma by regulating the p53 pathway
    Kong, Yang
    Zhang, Lufei
    Huang, Yu
    He, Tianyu
    Zhang, Linshi
    Zhao, Xinyi
    Zhou, Xiaohu
    Zhou, Dongkai
    Yan, Yingcai
    Zhou, Jiarong
    Xie, Haiyang
    Zhou, Lin
    Zheng, Shusen
    Wang, Weilin
    CANCER LETTERS, 2017, 407 : 76 - 83
  • [23] RASSF10 is Epigenetically Inactivated and Suppresses Cell Proliferation and Induces Cell Apoptosis by Activating the p53 Signalling Pathway in Papillary Thyroid Carcinoma Cancer
    Fan, Cheng
    Wang, Wendy
    Jin, Ji
    Yu, Zhuo
    Xin, Xiping
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2017, 41 (03) : 1229 - 1239
  • [24] Ubiquitination of P53 by E3 ligase MKRN2 promotes melanoma cell proliferation
    Zhang, Yiling
    Cui, Ningning
    Zheng, Gang
    ONCOLOGY LETTERS, 2020, 19 (03) : 1975 - 1984
  • [25] Combined CSL and p53 downregulation promotes cancer-associated fibroblast activation
    Procopio, Maria-Giuseppina
    Laszlo, Csaba
    Al Labban, Dania
    Kim, Dong Eun
    Bordignon, Pino
    Jo, Seung-Hee
    Goruppi, Sandro
    Menietti, Elena
    Ostano, Paola
    Ala, Ugo
    Provero, Paolo
    Hoetzenecker, Wolfram
    Neel, Victor
    Kilarski, Witold W.
    Swartz, Melody A.
    Brisken, Cathrin
    Lefort, Karine
    Dotto, G. Paolo
    NATURE CELL BIOLOGY, 2015, 17 (09) : 1193 - +
  • [26] Enhancement of p53 activity and inhibition of neural cell proliferation by glucocorticoid receptor activation
    Crochemore, C
    Michaelidis, TM
    Fischer, D
    Loeffler, JP
    Almeida, OFX
    FASEB JOURNAL, 2002, 16 (08) : 761 - 770
  • [27] Seeking Synergy in p53 Transcriptional Activation for Cancer Therapy
    Cheok, Chit Fang
    Lane, David P.
    DISCOVERY MEDICINE, 2012, 14 (77) : 263 - 271
  • [28] Correlation of survivin, p53 and Ki-67 in laryngeal cancer Hep-2 cell proliferation and invasion
    Pei, Shi-Geng
    Wang, Ju-Xiang
    Wang, Xue-Ling
    Zhang, Qing-Jun
    Zhang, Hong
    ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE, 2015, 8 (08) : 626 - 631
  • [29] miR-488-5p promotes esophageal squamous cell carcinoma progression by suppressing the P53 pathway
    Su, Chang
    Liu, Wenxiu
    Jiang, Tao
    Liu, Junfeng
    JOURNAL OF THORACIC DISEASE, 2021, 13 (09) : 5534 - 5545
  • [30] Gain-of-Function Mutant p53 Promotes Cell Growth and Cancer Cell Metabolism via Inhibition of AMPK Activation
    Zhou, Ge
    Wang, Jiping
    Zhao, Mei
    Xie, Tong-Xin
    Tanaka, Noriaki
    Sano, Daisuke
    Patel, Ameeta A.
    Ward, Alexandra M.
    Sandulache, Vlad C.
    Jasser, Samar A.
    Skinner, Heath D.
    Fitzgerald, Alison Lea
    Osman, Abdullah A.
    Wei, Yongkun
    Xia, Xuefeng
    Zhou Songyang
    Mills, Gordon B.
    Hung, Mien-Chie
    Caulin, Carlos
    Liang, Jiyong
    Myers, Jeffrey N.
    MOLECULAR CELL, 2014, 54 (06) : 960 - 974